ANIK Anika Therapeutics Inc

Anika Therapeutics Inc develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.

$40.28  +0.29 (0.73%)
As of 07/23/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/06/2001
Outstanding shares:  14,391,261
Average volume:  67,763
Market cap:   $575,506,527
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    035255108
ISIN:        US0352551081
Sedol:      2035754
Valuation   (See tab for details)
PE ratio:   -21.52
PB ratio:   2.09
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy